RoverMed's Ultra-Small Particle (CUSP), has the capability to bring our pharma partner's drugs right to their target no matter where the disease is in the body.
RoverMed’s precision targeted CUSP drug delivery technology enables biologic drugs that are dependent upon new delivery systems, to target, reach, and treat diseases. Billions are spent by pharmas developing new biologic drugs, but none will actually work unless there is a delivery technology that brings drugs right to their disease target. Partnering strategy provides immediate revenue. We already have 3 signed partnerships and strong pipeline.